P atients in a vegetative state/unresponsive wakeful ness syndrome 18 (VS/UWS) or in a minimally con scious state 8 (MCS) are characterized by preserved arousal but behavioral evidence of awareness of self and surroundings are absent (VS/UWS) or inconsistent (MCS).
ly disabled 1 year later. 10 Significant recovery in patients with a severe disorder of consciousness (DOC) admitted to an acute inpatient rehabilitation center mostly occurs within the 2 years after the initial injury. 23 The first clini cal study of deep brain stimulation (DBS) with the aim of improving recovery in patients with a DOC dates back to the pioneering research of Hassler et al. 13, 14 in 1969. Their study was conducted in an acute setting, and the patients underwent 15 minutes of daily stimulation of the anterior nucleus of the thalamus and globus pallidus; this stimula tion caused some improvements in the patients' level of reactivity to environmental stimuli and in electroencepha lographic (EEG) rhythms that lasted after the end of the stimulation. In the following decades, there were many at tempts to reproduce and improve the results of Hassler et al. by moving from acute to chronic longterm stimulation with fully implantable DBS devices and by exploring new targets, such as the centromedianparafascicularis nuclear complex of the thalamus 3, 4, 26, 28, 31 and the mesencephalic reticular formation. 28, 31 Independent of the target of stimu lation, the results of these cited studies indicated that DBS induces changes in the EEG pattern, such as an increase in higherfrequency rhythms and desynchronization, which makes the pattern more similar to that of otherwise healthy subjects. 5, 14, 32 All the study groups also described clinical improvements, although the results of their stud ies are difficult to compare because of large differences in the duration of the DOCs, changes in the classification of DOCs with the identification of the MCS, 8 and mul tiple developments in implanted hardware over the last 30 years. Despite intense interest in the potential applications of DBS to patients with a DOC, as shown by the publi cation of several recent reviews of the data available, 19, 27 results of new studies on multiple patients affected by a DOC have not been reported recently.
Here, we report the longterm results of the Cortical Ac tivation by Thalamic Stimulation (CATS) study (clinical trial registration no.: NCT01027572 [ClinicalTrials.gov]), a prospective multiinstitutional study started in 2009 that examined the effects of bilateral DBS of the anterior intra laminar thalamic nuclei and adjacent paralaminar regions of thalamic association nuclei in patients in a VS/UWS or MCS. The primary end point of the study was variation in the level of patient consciousness as indicated by modi fied Coma Recovery Scale-Revised (CRS-R) 9,15,20 scores (Table 1) at least 1 year after bilateral thalamic stimulation of the anterior intralaminar thalamic nuclei and adjacent paralaminar regions. The secondary end point was change in the EEG power spectrum after the same period of bilat eral stimulation of the thalamus in the same patients.
methods
Patients of both sexes aged between 10 and 65 years af fected by a DOC that had lasted more than 6 months were enrolled in the CATS study. The research protocols were approved by the institutional review board of the Fondazi one Instituto Ricerca Cura Carattere Scientifico (IRCCS) Policlinico S. Matteo (Pavia, Italy) and later revised and approved by the institutional review boards of the Fon dazione IRCCS Maugeri (Pavia) and Fondazione IRCCS Istituto Neurologico Nazionale C. Mondino (Pavia) when they joined the study. Informed consent was obtained for each patient from his or her legal representatives, and eval uation of each patient for enrollment into the study started after request by the person with legal responsibility for the patient. The study was conducted in accordance with the Declaration of Helsinki.
The accepted initial etiologies that led to the patients' DOC were head trauma, spontaneous intracranial hemor rhage, and transient anoxic insult. The level of the DOC affecting the subject was evaluated by using the Italian version of the CRS-R. 20 Any patient who had no objective indications of a stable DOC noted in the clinical records submitted at the time of the initial request to enter the study was rejected without further consideration.
Inclusion criteria were based on clinical (Table 2) , neu rophysiological (Table 3) , and neuroradiological (Table 4) findings.
Exclusion criteria were the following: further neuro logical disease independent of the pathology that caused the DOC, a life expectancy of less than 1 year because of extraneurological diseases, an ongoing noteradicable infection, pregnancy, untreated hydrocephalus, and a re quest from the legal representative to exclude the patient from the study.
Each patient was independently examined by 2 inves tigator teams both before and after DBS surgery and at scheduled followup controls, which comprised a thorough clinical evaluation including but not limited to the admin istration of the CRS-R and Sections 2 and 3 of the Unified * The lowest score on each subscale indicates purely reflexive activity or the lack thereof, whereas the highest score indicates cognitively mediated behavior. Scoring is based on the presence or absence of specific responses to standardized stimuli organized hierarchically in 29 items. 15 Total scores ≤ 9 are indicative of a VS/UWS unless one or more subscores of the CRS-R subscales exceeds the maximum limits indicated in column 3 (VS/UWS). Total scores > 9 but ≤ 21 are indicative of an MCS unless one or more of the subscores of the CRS-R subscales exceeds the maximum limits indicated in column 4 (MCS). † Range shows scores from minimum to maximum. Myoclonus Rating Scale 7 (UMRS), electroencephalogra phy, and visual and somatosensory evoked potentials with the stimulator on and with it off. After the evaluations, the independently obtained scores were compared, and any differences were jointly discussed. Differences in CRS-R scores by the 2 teams were rare, and the difference in the total scores of the 2 teams was never greater than 1. My oclonus was also evaluated by 2 independent teams before and after DBS surgery. After DBS, all the evaluators were aware that the subject had undergone surgery, but they did not know if the stimulator was on or off.
The study required that, at the end of the 1st year of thalamic DBS, the legal representative of the patient for mally request that the stimulation be continued or that it be stopped. If the representative requested that the stimu lation be stopped, he or she also had to decide between simple inactivation of the stimulator or removal of all the implanted devices.
Neuroradiological examinations
Preoperative and postoperative MRI of each patient's brain was performed with a 1.5T apparatus. For each patient, T1weighted images (obtained with and without contrast) and T2weighted images were acquired volumet rically and used for all the neuroanatomical evaluations. Volumes were calculated after identification of the regions of interest with the help of OsiriX software (Pixmeo).
surgical procedure
After the induction of anesthesia in the patient, the CRW stereotactic head frame (Integra-Radionics) was po sitioned, and the patient then underwent intravenous con trast-enhanced MRI and CT. After fusion of the MRI with the CT scan, the images were registered to an electronic version of the Schaltenbrand and Wahren stereotactic atlas (Integra-Radionics). Because of brain atrophy and altera tions peculiar to each patient that resulted from traumatic brain injury, the atlas data had to be complemented with electrophysiological indications. We targeted the anterior intralaminar thalamic nuclei and adjacent paralaminar regions 26 starting from a bur hole (5 mm in diameter) lo cated in the ipsilateral parietal bone. Five microelectrodes (microTargeting Model 22670, FHC Bowdoinham), which were 2 mm apart from each other, in 2 patients and 4 mi croelectrodes in 1 patient were guided to the target using the Ben Gun tool with 5 parallel channels.
The electrodes were advanced in 1mm steps from 15 mm before the target to 10 mm after it. After recording was done, the microelectrodes were removed, and a defini tive quadripolar electrode (Model 3387, Medtronic Italia S.p.A.) was positioned with the second contact from the tip corresponding to the target position. The definitive elec trodes were externalized through a disposable connecting cable for neurophysiological monitoring and testing dur ing the first postoperative week. After that period, with the patient in a state of general anesthesia, the electrodes were connected with extension cables to a Kinetra pulse genera tor (Model 7428, Medtronic Italia S.p.A.) implanted in the right thoracic wall. The position of the electrodes relative to the thalamus was confirmed by postoperative CT scan ning and MRI (Fig. 1) . 
stimulation parameters
During the initial testing phase, which lasted for 7 days, a wide variety of combinations of electrode contacts and stimulation parameters, including a trial with low stimula tion frequency (less than 40 Hz), were tested through the exteriorized leads of the electrodes. The individualized re sults of the initial phase enabled us to choose the definitive stimulation parameters that were further optimized on the basis of the clinical and electrophysiological responses of the patients in the months after stimulator implantation.
assessment of the patients by caregivers and relatives
By interviewing and collecting all spontaneous decla rations of the patients' caregivers and relatives, we system atically assessed the degree of psychological discomfort induced in them by the surgical procedures and the fol lowing period of DBS stimulation in the patients. Using the same methods, we also evaluated the temporal evo lution of their assessment of the degree of worsening or improvement that DBS induced in the patients' status and in their ability to manage them.
Neurophysiology
Multichannel EEG (SystemPLUS, Micromed) re cordings were obtained before and after surgery with a sampling rate of 2048 Hz and an analogtodigital con verter resolution of 16 bits with a standard montage (16 electrodes). Auditory, visual, and somatosensory evoked potentials were recorded using standard stimuli and the same apparatus used for EEG recordings.
EEG signals were first filtered in the frequency range (1-40 Hz) in which we found approximately 99% of the signal power spectrum and then further parted by a finite impulse response filter (0.3-Hz width) in the 5 bands: delta (1-4 Hz), theta (4-8 Hz), alpha (8-13 Hz), beta (14-30 Hz), and low gamma (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) . The fast Fourier transform EEG power spectrum was estimated by the spectopo.m function of EEGLAB, an opensource toolbox for the analysis of singletrial EEG dynamics. 6 
statistical analysis
Statistical analyses and graphic rendering were per formed with the help of MedCalc version 14.8.1.
patients

Patient 1
Eight years before the implantation of DBS electrodes into the thalami, this 29yearold man was involved in a car accident in which he suffered a closed head injury. The patient immediately lost consciousness and never re gained it; findings on the initial CT and MR images were compatible with diffuse axonal injury. During the initial management, an external ventricular drain was positioned in the right lateral ventricle. After the initial trauma, the patient never regained consciousness and remained insti tutionalized in a VS/UWS. He was able to breathe without mechanical support through a tracheostomy; his cardio vascular, respiratory, renal, and gastrointestinal functions were normal. He had generalized spasticity with bilateral myoclonic mass movements. Opsoclonic and myoclonic movements could be evoked or exaggerated by minor tactile stimulation or environmental sounds (startle my oclonus); spontaneous bilateral opsoclonus was also often present and persisted for hours once it started. The CRS-R score at the time of electrode implantation was 6. The followup period was 59 months.
Patient 2
Two years and 10 months before the implantation of DBS electrodes into the thalami, this 23yearold man was involved in a car accident that resulted in bilateral frontal acute subdural hematoma associated with multiple parenchymal lacerations. On the same day of the injury, the patient underwent surgery for evacuation of the hema tomas and decompressive craniectomy. Four months after the initial surgery, he underwent cranioplasty with autolo gous bone. After the initial trauma, he never regained con sciousness and remained institutionalized in a VS/UWS. He was able to breathe, and his cardiovascular, respiratory, renal, and gastrointestinal functions were normal. He had generalized spasticity and evoked myoclonus. The CRS-R score at the time of electrode implantation was 8. The followup period was 60 months.
Patient 3
Two years and 4 months before the implantation of DBS electrodes into the thalami, this 58yearold man was involved in a car accident that resulted in multiple lacera tions and contusions in frontal lobes bilaterally and the right parietal lobe; a subarachnoid hemorrhage was also present. He was treated conservatively and was never submitted to neurosurgical treatment with the exception of a right frontal intraparenchymal catheter being placed for measuring his intracranial pressure. After the initial trauma, he never regained consciousness, although he showed initial improvement from VS/UWS to MCS (he sometimes moved his right hand on request). He was insti tutionalized after discharge from the hospital in which he was initially treated. His CRS-R score at the time of elec trode implantation was 14. The followup period was 18 months, at the end of which all the implanted devices were removed because of a scalp infection, as described below.
results study participants
Of 40 patients evaluated for entry into the study, 14 had had a traumatic event, 20 had had an initial hypoxic/ ischemic insult caused by cardiac arrest, and 6 had had a spontaneous intracerebral hemorrhage; only 5 patients met all the eligibility criteria, and 3 underwent bilateral thalamic electrode implantation. The most common cause of exclusion was the presence of anatomical damage of the brain that exceeded the criteria listed for the study. Of the 2 patients who met all the eligibility criteria but did not proceed to undergo surgery, 1 exited the study because his legal representative chose to give priority to orthopedic surgery, which caused an excessive delay, and there were unexpected problems in the determination of the legal rep resentative of the other patient.
clinical outcomes
After individualized clinical trials with a combination of stimulation parameters, we found that, for all patients, highfrequency stimulation (median 100 Hz, minimum 80 Hz, maximum 110 Hz) was more efficient than lowfrequency stimulation (< 40 Hz) in improving the patients' status and decreasing unwanted effects (e.g., spasms, per sistent fear expression). Two patients had more adverse effects related to unipolar stimulation and therefore were chronically stimulated in bipolar mode, whereas 1 patient was stimulated in unipolar mode. Stimulation ended at 9:00 Pm and restarted early in the morning at 7:00 am. Af ter the start of DBS, the average (± SD) CRS-R scores im proved from 1.67 ± 1.53 after 6 months of stimulation to 2 ± 1.53 after 12 months and to 2.33 ± 1.15 after 18 months. For the 2 patients who continued DBS after 18 months, the average improvement in CRS-R scores from the preopera tive score at 4 months was 3 ± 0.00 and remained stable up to 4 years.
Another favorable result of the stimulation was the large improvement in the severity and frequency of my oclonus, opsoclonus, and spasticity that we observed in all the patients; the larger effects were seen in the patients in a VS/UWS (Patients 1 and 2 ). Myoclonus was assessed by using the sum of the scores (range 0-125) of Sections 2 (rest subscore range 0-108) and 3 (stimulus sensitivity subscore range 0-17) of the UMRS 7 (Fig. 2 right) . The reduction in the resting myoclonus subscores in the 2 pa tients who had this problem before electrode implantation was remarkable, whereas their stimulusevoked myoclonic movements were less affected. Effects on spasticity and myoclonus largely depended on ongoing stimulation, as shown by the reversal of the beneficial action of stimula tion on resting myoclonus 1 hour after the stimulation was stopped. The beneficial effects of stimulation on spastic ity did not revert completely when the stimulator was off, because muscle tone remained less than that before DBS when tested by passive movements.
Apart from their initial stress related to the electrode implantation, which quickly resolved, the caregivers and relatives were always relieved by the positive effects of the thalamic stimulation on spasticity and myoclonus and by their own impression of an improved response to behavioral stimulation. Moreover, at the end of the first year of stimulation when, according to the protocol, the legal representatives had to decide whether to halt DBS, all of them independently opted for continuing the treat ment even though none of the patients had regained full consciousness.
Neurophysiological outcomes
Visual, acoustic, and somatosensory (N20/P25 bilat eral median nerve stimulation) evoked potentials did not change significantly after DBS. After 1 month of stimula tion, the EEG power spectrum showed increased power at the theta and gamma frequencies (Fig. 3) . Overall, the EEG spectral power increased in all patients and for all bands except for the alpha and beta bands in the patient in an MCS (Fig. 4) . These changes were stable and de pended on DBS stimulation. We obtained further indica tions that DBS modulated the EEG activity of the patients by independent component analysis (ICA). We computed the power of ICA components before and after DBS with the stimulator on or off. We consistently found that pre DBS and postDBS component power distributions on the scalp were remarkably similar when the stimulator was off, whereas significant differences were observed with the stimulator on (Fig. 5 ).
complications
The surgery was well tolerated by all 3 patients. The initial CT images of the brain, which were required by pro tocol within 12 hours after implantation of the electrodes, showed an intraparenchymal hematoma in the right pari etal lobe, close but not concentric to one of the electrode tracks, in Patient 3 (Fig. 6) . Considering the lack of signifi cant mass effect and the stability of the clinical features of the patient, we treated the hematoma conservatively and did not remove the electrode. There were no periop erative infections. Seventeen months after implantation of the DBS electrodes, Patient 3 developed a scalp infection (Pseudomonas aeruginosa) with multiple small ulcers that caused limited exteriorization of one of the electrocatheter extensions. The infection started from a small superficial wound and presumably resulted from excessively vigorous combing during daily care. After a limited trial of intra venous antibiotic treatment (1 g of meropenem 3 times/ day), we discussed the situation with the patient's family and the person who was legally responsible for him, who finally decided for surgical removal of all the devices im planted for DBS. The surgery to remove the hardware was uneventful, and the infection resolved after 1 more week of antibiotic therapy.
discussion
The results of our prospective multiinstitutional trial in volving patients in a VS/UWS or MCS suggest that bilater al stimulation of the anterior intralaminar thalamic nuclei and adjacent paralaminar regions improves the clinical status of the patients treated. In our experience, clinical improvement occurred in the patients in a VS/UWS and in the patient in an MCS despite the initial injuries having occurred more than 2 years (median 34 months, minimum 28 months, maximum 96 months) before DBS. Spontane ous improvements in patients with a severe DOC of post traumatic origin happen mostly within 2 years after the initial injury. 23, 28, 30 Thus, the improvements in the CRS-R scores seen in our patients are unlikely to have been spon taneous. The beneficial effects on spasticity and myoclo nus were also a significant part of the clinical improve ment. These effects were directly related to stimulation and decayed rapidly after turning off the stimulator. Tha lamic DBS has already been described for the treatment of myoclonus caused by perinatal anoxia 16 and in myoclonus dystonia syndrome. 12, 17 Thalamic electrodes for the treat ment of myoclonus are usually positioned into the ventral intermediate nucleus of the thalamus, 25 which is located far from our target even when taking into account the rela tive shrinkage and distortion of the thalamus commonly seen in patients with a DOC. However, there are indica tions that stimulation of the centromedianparafascicularis nucleus may also modulate motor output. 2 Previous studies with electrodes implanted unilaterally or bilaterally in the thalamus have resulted in a generalized increase in EEG frequency and desynchronization; 5,32 these changes, how ever, were not necessarily predictive of recovery of con sciousness. 5, 32 In our experience, bilateral thalamic stimu lation induced statistically significant increments of the EEG spectral power in all patients and for all frequency bands with the exception of the alpha and beta bands in the patient in an MCS. We obtained further indications that stimulation induced changes in cortical activity by ICA 34 of the EEG activity recorded before and during DBS. In all patients, the activation maps obtained with the stimulator off were similar to those obtained before DBS implanta tion, but they differed when the stimulator was on. Initial studies that used DBS in patients with a DOC were per formed before the identification of MCS 8 as a condition that is substantially different from VS/UWS. 18 It was sug gested more recently that only patients in the upper end of an MCS could benefit from thalamic DBS. 26 This opinion is not supported by either our results, which show that 2 patients in a VS/UWS for more than 2 years had improve ments in their status and moved from a VS/UWS to an MCS after DBS, or the data from previous studies. 3, 32, 33 However, previous data that supported positive effects of DBS in patients in a VS/UWS were obtained from patients treated by DBS after only 3-8 months of stable VS/UWS, a period too short to rule out spontaneous recovery. 26, 28 As demonstrated by MRI and postmortem studies, overall structural brain integrity is less affected in patients in an MCS than in those in a VS/UWS. 1 However, functional MRI (fMRI) studies performed to evaluate preserved awareness in the absence of reliable communication found that some patients in a VS/UWS, and some patients in an MCS, had specific brain-activation patterns reflecting awareness and cognition. 21, 22 In our study, the patient in an MCS had improvements in CRS-R scores but did not reach consistent communica tive behavior; the same was true for the 2 patients in a VS/UWS. The difference between our results and those of Schiff et al. 26 may be at least partially due to the difference in the level of MCS, because our patient did not mouth sin gle words on prompting. The intracerebral hematoma lo cated close to the track of the right stimulating electrode is unlikely to have been the cause of the incomplete results in our patient in an MCS, because the baseline CRS-R score (determined before electrode implantation) remained the same after complete resolution of the hematoma. In con clusion, our study results suggest that stimulation of the thalamus in patients with a DOC improves the reactivity of the patients to the environment and decreases spasticity and myoclonic movements. The patients' caregivers and relatives had favorable opinions of DBS during the entire first year and continued to remain in favor of it in the fol lowing years, even though the patients never reached con sistent, explicitly communicative behavior.
Our study also had limitations. Five patients entered the study, and only 3 patients finally underwent thalamic DBS. However, our 3 patients, who were accrued for the study within a 2year period, should be considered in the light of recent publications that were either based on a single patient 26 or, even if they involved a higher number of pa tients, were not prospective and had accrual periods longer than 10 years. 3, 32 With overly protracted accrual periods, significant changes in hardware and sometimes even in the targets of the stimulation can occur. 32 All these confound ing factors limit the advantage of the increased numeros ity of the sample. Our inclusion and exclusion criteria did not incorporate fMRI results, which may have helped to distinguish among patients with a DOC and those with a higher potential to respond to thalamic DBS. 24 However, our study was designed in 2007, before the publication of any study clearly demonstrating the clinical relevance of fMRI in the assessment of patient ability to generate will ful responses during mental imagery tasks. 22, 29 Moreover, our study was open to all patients with a DOC, and predic tion of the clinical course of such patients by fMRI seems to be less accurate in patients in an MCS than in those in a VS/UWS. 29 The inclusion/exclusion criteria of our study reflected our goal of including patients in a VS/UWS and those in an MCS, provided their status was stable and there were no doubts in assigning them to one or the other group. As a minimal requirement for thalamic DBS, we excluded patients with obvious lesions of the thalami as assessed by MRI and/or bilateral lack of sensory evoked potentials (somatosensory and visual). We also excluded all patients with large lesions affecting the dominant hemisphere or both the frontal lobes, which are invariably associated with severe neurological disorders (e.g., global aphasia) that could abolish the benefits of any potential improve ment in selfawareness. 11 Despite our minimalistic exclu sion criteria, more than 87.5% of the patients initially eval uated as potential candidates were excluded because MRI proved anatomical damage of the brain that exceeded the admission criteria.
conclusions
Our study results suggest that the majority of patients with a DOC do not meet the minimal criteria of brain connectivity and tissue preservation that are required for attempting thalamic DBS to improve their condition. Pa tients with a DOC who met the minimal criteria and pro ceeded to undergo DBS experienced objective improve ments in their condition, as shown by increases in their CRS-R scores. However, we should consider that the lead ing motivation for society to sustain the cost of DBS in patients with a DOC should be restoration of consistent communicative behavior. Based on our experience and the results of more than 50 years of previous attempts, this is still an unlikely result of thalamic DBS in patients with a DOC.
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